中国医药行业市场研究分析(英文105页)

    2013-11-17

中国医药行业市场研究分析(英文105页)


Table of Contents

IMS MARKET PROGNOSIS .........6

MARKET OVERVIEW AND FORECASTS .........7

MARKET SYNOPSIS ............ 7
TOTAL MARKET FORECASTS 2012-2016 ........... 9
ANALYSIS OF REBATES AND DISCOUNTS .............. 9
SUMMARY OF THE PROGNOSIS .......... 9
HOSPITAL SECTOR OVERVIEW ............. 11
HOSPITAL SECTOR FORECASTS ........ 13
EVENT ANALYSIS ............. 15
FORECASTING DATA AND METHODS ............. 20
DATA SOURCES ........... 20
BASELINE EXTRAPOLATIONS ........... 20
HOSPITAL SECTOR BASELINE EXTRAPOLATIONS ........... 21
ECONOMIC INDICATORS ........ 22
THERAPEUTIC CLASS FORECASTS ........ 23
IMS MARKET PROGNOSIS REPORT ...........25
BUSINESS ENVIRONMENT ...............26
ECONOMIC ENVIRONMENT ......... 26
ECONOMIC GROWTH ............. 26
INFLATION ......... 26
POPULATION, EMPLOYMENT AND INCOME ........... 26
FISCAL POLICY ............. 27
MONETARY POLICY ................ 27
FOREIGN TRADE AND CURRENT ACCOUNT ........... 27
EXCHANGE RATE .......... 28
POLITICAL ENVIRONMENT .......... 30
POLITICAL INSTITUTIONS ............... 30
CURRENT GOVERNMENT ......... 30
18th PARTY CONGRESS 2012 ........... 31
WUKAN VILLAGE PROTEST .............. 32

INTERNATIONAL RELATIONS ............ 32

HEALTHCARE ENVIRONMENT ...........33

HEALTHCARE PROVISION ........... 33
Market Prognosis Scenario 2012-2016: Healthcare Provision ............. 33
HEALTHCARE SYSTEM ............ 34
HEALTH STATUS ........... 36
HEALTHCARE FINANCING AND EXPENDITURE ............... 38
 
PHARMACEUTICAL EXPENDITURE .............. 38
HEALTHCARE POLICY ............. 41
DRUG POLICY .............. 42
HEALTH INSURANCE .............. 43
HOSPITAL SECTOR ................ 45
HOSPITAL DRUG PROCUREMENT ............... 48
COMMUNITY CARE ........ 50
PRESCRIBING AND DISPENSING .......... 52
Market Prognosis Scenario 2012-2016: Prescribing and Dispensing ............. 52
PRESCRIBING INFLUENCES .............. 52
ANTIBIOTIC PRESCRIBING .............. 55
ESSENTIAL DRUG LIST ........... 56
NATIONAL REIMBURSEMENT DRUG LIST ............. 56
PATIENT CO-PAYMENT ........... 58
HOSPITAL FORMULARIES ................ 58
PRESCRIPTION-ONLY POLICY ........... 58
SEPARATION OF PRESCRIBING AND DISPENSING .......... 58
PRICING ................ 59
Market Prognosis Scenario 2012-2016: Pricing .............. 59
PRICING SYSTEM ......... 59
PRICING POLICY REFORM ................ 60
PRICE MONITORING .............. 62
PRICE CUTS ........ 62
PRICE TRENDS ............. 63
PHARMACOECONOMICS ......... 64
DISCOUNTS AND MARGINS ............. 64
REGULATORY ENVIRONMENT ............... 66
Market Prognosis Scenario 2012-2016: Regulatory Environment ........ 66
STATE FOOD AND DRUG ADMINISTRATION ......... 67
PRODUCT REGISTRATION ................ 67
CLINICAL TRIALS ......... 68
GOOD MANUFACTURING PRACTICE ............ 68
POST-MARKETING SURVEILLANCE ............. 69
MARKETING AND PROMOTION ......... 69
COUNTERFEITS ............ 70
INTELLECTUAL PROPERTY ................ 70
PHARMACEUTICAL BUSINESS ENVIRONMENT .......... 72
Market Prognosis Scenario 2012-2016: Pharmaceutical Business Environment ................ 72
OPERATING ENVIRONMENT ............. 73
INDUSTRY STRUCTURE .......... 74
LEADING CORPORATIONS ............... 76
LEADING PRODUCTS .............. 77
FOREIGN INVESTMENT ........... 77
RESEARCH AND DEVELOPMENT ........ 78
GENERICS MARKET ................ 79
DISTRIBUTION ............. 80
RETAIL PHARMACY ................ 81
OTC MARKET ............... 82
SALES AND MARKETING ......... 83

APPENDIX A: GLOSSARY ........85

APPENDIX B: SOURCES AND METHODS .............87

COVERAGE ............. 87
MARKET FORECASTS ............. 88
MARKET SEGMENTATION FORECASTS ........ 88
THERAPEUTIC CLASS FORECASTS ............. 88
REGIONAL OVERVIEWS .......... 89
FORECASTING METHODOLOGY ............ 90
TOTAL MARKET FORECASTING PROCESS ............. 90
MARKET SEGMENTATION FORECASTING PROCESS ........ 91
THERAPEUTIC CLASS FORECASTING PROCESS .............. 93
SOURCES ............... 94
PRIMARY AND SECONDARY MARKET RESEARCH ............ 94
PHARMACEUTICAL MARKET DATA .............. 94
PHARMACEUTICAL MARKET COVERAGE .......... 95
EVENT IMPACT CALCULATION .............. 96
DEMOGRAPHIC CHANGES ................ 96
NEW PRODUCT LAUNCHES ............... 99
CALCULATION OF GENERIC COMPETITION ........... 99
USEFUL DEFINITIONS .............. 101
COMPOUND ANNUAL GROWTH RATE ........ 101
CONSTANT PRICE ................ 101
LASPEYRES INDEX ............... 101
STANDARD UNITS ............... 102
GENERIC DEFINITION USING THE IMS MIDAS MARKET SEGMENTATION FEATURE ........ 102
GENERIC DEFINITION WITHOUT THE MARKET SEGMENTATION FEATURE ............ 103
[报告关键词]:   医药  
合作共赢,共创未来

需要行业报告相关资料和报告?

每年为数千个企事业和个人提供专业化服务;量身定制你需要的行业报告的资料和报告

相信我们!企业客户遍及全球,提供政府部门、生产制造企业、物流企业、快消品行业专业化咨询服务;个人客户可以提供各类经济管理资料、商业计划、PPT、MBA/EMBA论文指导等。

点此填写您的需求

15+年的经验,值得信赖

可以QQ联系我们:896161733;也可以电话:18121118831

**涉及个人信息严格保密,敬请放心

商务服务

可以微信或者电话联系:18121118831

商业计划书

商务文档撰写

提供商业计划书、投资计划书咨询、撰写和指导

点击查看详细

可行性研究报告

商务咨询业务

服务企业、政府和投资者,提供各个产业可行性研究报告撰写和咨询服务

点击查看详细

物流产业园区规划

商务咨询业务

为企业提供物流园区规划咨询,包括市场调研、可行性、总体战略和运营规划等等

点击查看详细

PPT设计制作

商务PPT制作

商业计划书是一份全方位的项目计划,它从企业内部的人员、制度、管理以及企业的产品、营销、市场等各个方面对即将展开的商业项目进行可行性分析(包含论文PPT)。

点击查看详细